Get started
Author

Behzad Fatemi

Observed name: Fatemi, Behzad
ORCID: 0000-0001-7912-7546
Observed ORCID: 0000-0001-7912-7546
OpenAlex ID: A5069422002
Reasons for poor blood pressure control in Eastern Sub-Saharan Africa: looking into 4P’s (primary care, professional, patient, and public health policy) for improving blood pressure control: a scoping review
2021 · Mende Mensa Sorato, Majid Davari, et al. · BMC Cardiovascular Disorders · 60
PDF
Efficacy and safety of Tocilizumab in severe and critical COVID-19: A Systematic Review and Meta-Analysis
2021 · Soheila Rezaei, Behzad Fatemi, et al. · Expert Review of Clinical Immunology · 33
Trends analysis and future study of medical and pharmacy education: a scoping review
2025 · Manuchehr Bashirynejad, Fatemeh Soleymani, et al. · BMC Medical Education · 13
PDF
Trends analysis and future study of the pharmaceutical industry field: a scoping review
2024 · Manuchehr Bashirynejad, Fatemeh Soleymani, et al. · DARU Journal of Pharmaceutical Sciences · 12
PDF
Cost-effectiveness analysis of tofacitinib compared with adalimumab and etanercept in the treatment of severe active rheumatoid arthritis; Iranian experience
2020 · Behzad Fatemi, Soheila Rezaei, et al. · Expert Review of Pharmacoeconomics & Outcomes Research · 11
First Iranian guidelines for the diagnosis, management, and treatment of hyperlipidemia in adults
2024 · Fahimeh Bagheri Kholenjani, Shahla Shahidi, et al. · Journal of Research in Medical Sciences · 10
Medical therapy versus percutaneous coronary intervention or coronary artery bypass graft in stable coronary artery disease; a systematic review and meta-analysis of randomized clinical trials.
2022 · Majid Davari, Mende Mensa Sorato, et al. · PubMed Central · 9
PDF
Development of the first Iranian clinical practice guidelines for the diagnosis, treatment, and secondary prevention of acute coronary syndrome
2024 · Nizal Sarrafzadegan, Fahimeh Bagherikholenjani, et al. · Journal of Research in Medical Sciences · 8
Efficacy of intravenous immunoglobulins (IVIG) in COVID-19 patients: a systematic review and meta-analysis
2023 · Behzad Fatemi, Soheila Rezaei, et al. · Research in Pharmaceutical Sciences · 7
Trastuzumab deruxtecan versus trastuzumab emtansine for human epidermal growth factor receptor 2 positive metastatic breast cancer: cost-effectiveness analysis from Iranian experience
2025 · Neda Yaghoubi, Behzad Fatemi, et al. · BMC Health Services Research · 6
PDF
Efficacy and safety of insulin detemir versus glargine in patients with diabetes: a systematic review and meta-analysis
2022 · Soheila Rezaei, Ali Taheri, et al. · Expert Review of Clinical Pharmacology · 5
Risk of fatal and nonfatal coronary heart disease and stroke events among adult patients with hypertension: basic Markov model inputs for evaluating cost-effectiveness of hypertension treatment: systematic review of cohort studies
2021 · Mende Mensa Sorato, Majid Davari, et al. · Journal of Pharmaceutical Health Services Research · 5
Cost-effectiveness analysis of tofacitinib for the treatment of moderate to severe rheumatoid arthritis: a systematic review and meta-analysis
2024 · Behzad Fatemi, Neda Yaghoubi, et al. · Expert Review of Pharmacoeconomics & Outcomes Research · 4
How do patients value features of biological medicine in rheumatoid arthritis? A discrete choice experiment
2023 · Saman Zartab, Shekoufeh Nikfar, et al. · Expert Review of Pharmacoeconomics & Outcomes Research · 4
Cost-Utility Analysis of Erenumab Compared to Topiramate for Preventive Therapy of Migraine in Iran
2024 · Hosein Mollaee, Sadra Nadimi Parashkouhi, et al. · Iranian journal of pharmaceutical research · 3
PDF
Cost-utility analysis of blinatumomab in pediatric patients with acute lymphoblastic leukemia in Iran
2025 · Golara Nikakhtar, Zahra Amiri, et al. · Immunotherapy · 1
PDF
Is There Any Benefit in Extended-Interval Dosing Regimen of Natalizumab for Patients with Relapsing-Remitting Multiple Sclerosis? Results from a Systematic Review and Meta-Analysis
2023 · Taraneh Mousavi, Behzad Fatemi, et al. · Multiple Sclerosis and Related Disorders · 1
Factors associated with re-hospitalization and status of risk factors among patients with stable coronary artery disease referred to Medical therapy: Unmatched cohort study
2021 · Majid Davari, Mende Mensa Sorato, et al. · Iranian Red Crescent Medical Journal · 1
PDF
Cost-Effectiveness Analysis of Carfilzomib vs Bortezomib in Relapsed/Refractory Multiple Myeloma in Iran
2026 · Neshaut Mashreghi Mohammadi, Behzad Fatemi, et al. · Value in Health Regional Issues
Artificial Intelligence in Pharmacovigilance: Current Landscape, Key Challenges, and the Future of Drug‑Safety Automation — A Scoping Review Protocol
2026 · Seyed Ali َASghar Bakhtar, Behzad Fatemi
Affordability Analysis of Selected Medicines in Iran: A National Cross-sectional Survey Using World Health Organization Out-of-Pocket Methodology
2026 · Fatemeh Soleymani, Amirhossein Abdi, et al. · Iranian journal of pharmaceutical research
PDF
Pharmaceutical Utilization Review: A Five-Year Time Trend Analysis of the Pharmaceutical Market in Iran
2026 · Mohammadamir Nemati, Behzad Fatemi, et al. · Iranian journal of pharmaceutical research
PDF
Cost-utility analysis of Lenvatinib vs. Sorafenib in unresectable hepatocellular carcinoma in Iran
2025 · Mohammad Mahdi Raeis Zadeh, Behzad Fatemi, et al. · Expert Review of Pharmacoeconomics & Outcomes Research
Cost-utility analysis of combination medical therapies in chronic coronary syndrome: a comparative study using real-world and patient-level data from Iran
2025 · Majid Davari, Behzad Fatemi, et al. · BMJ Open
PDF
Efficacy and safety of insulin detemir versus glargine in patients with diabetes: a systematic review and meta-analysis
2022 · Rezaei, Soheila, Taheri, Ali, et al. · Figshare
Works count: 34
Citation count: 193
H-index: 8
I10-index: 6
Year
Topic
Type